Medicaid prescription drugs : CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs : report to congressional requesters.

Author/Creator:

United States. Government Accountability Office, issuing body.

Standardized Title:

Medicaid prescription drugs (2013 December)

Other Title:

Medicaid prescription drugs : Centers for Medicare & Medicaid Services should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs
CMS should implement revised federal upper limits and monitor their relationship to retail pharmacy acquisition costs

Edition:

Revised.

Publication:

[Washington, D.C.] : United States Government Accountability Office, 2013.

Format/Description:

Government document
Book
1 online resource (iii, 40 pages) : illustrations

Subjects:

Medicaid -- Claims administration.
Prescription pricing -- United States.
Centers for Medicare & Medicaid Services (U.S.) -- Rules and practice.

Notes:

Title from title screen (viewed Feb. 13, 2014).
"December 2013."
"This report was revised on February 6, 2014 to correct the omission of reprinting written comments from the Department of Health and Human Services (HHS) on a draft report. A copy of the HHS's written comments was inserted in appendix V."
Includes bibliographical references.
"GAO-14-68."
GPO Cataloging Record Distribution Program (CRDP).

OCLC:

872279639

Online:

Connect to full text
https://purl.fdlp.gov/GPO/gpo46110

Loading...